Definitive Contract HHSN261200900076C
Award Date
9/30/09
Potential Completion Date
3/30/10
Potential Value
$200K
Federal Agency
National Cancer Institute
Awardee
Synergene Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20854, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanospectra Biosciences, Inc. for "Targeted Photothermal Ablation of Melanoma". The contract has a firm fixed price ceiling of $200,000.00 and a period of performance ending on September 23, 2011. As an SBIR Phase I award, this contract is focused on feasibility research and development of the proposed technology.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Biocure Inc. for the development of "Targeted Multifunctional Polymersomes for Cancer Therapy". The contract is a Firm Fixed Price Definitive Contract with a ceiling value of $199,889. The period of performance is from the award date of September 30, 2009 to the ultimate completion date of July 31, 2010. This SBIR Phase I contract is focused on...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanotarget LLC for the development of a nanoparticle CD8 T cell regimen for cancer therapy. The firm-fixed-price contract has a ceiling value of $174,251 and a period of performance ending on May 31, 2010. No subcontractors are mentioned. The SBIR program supports research and development of innovative technologies by small businesses to address key...
<p>This is a $200,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Aspen Medisys, Inc. The contract is for the development of magnetically energized nanoparticles for treating ovarian cancer. The period of performance runs from the award date of September 24, 2010 through the ultimate completion date of August 23, 2011.</p>
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Imaginab, Inc. The contract, valued at $224,264, is for the development of novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and treatment. The contract has a firm fixed-price pricing type and a completion date of September 29, 2012.</p>
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Zymera Inc., a small disadvantaged business. The contract has a ceiling value of $199,948.00 and is for the development of homogeneous nanoparticle-based systems for protease detection. The contract was awarded on September 30, 2009 with a completion date of June 29, 2010. As this is an SBIR Phase I contract, it is a small business set-aside.</p>
This is a $144,220 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Magarray, Inc. for the development of early diagnostic tools using nanotechnology-based imaging and sensing. The contract was awarded on September 28, 2007 and has a completion date of March 27, 2008. Magarray, Inc. is a for-profit manufacturer located in Mountain View, California. The contract is a firm fixed-price definitive contract, which...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Targagenix, Inc. for R&D on a nanoemulsion formulation and IND-enabling studies of a novel cancer stem cell cytotoxic agent. The definitive, firm-fixed-price contract has a ceiling value of $2,284,577.00 and a period of performance ending on October 15, 2018. As an SBIR Phase I award, this contract supports early-stage research and development...
This is a $200,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Nanomaterial Innovation LTD, a woman-owned limited liability company. The contract is for the development of "MULTIFUNCTIONAL SIRNA NANOPARTICLES FOR AML THERAPY", which aligns with NCI's research focus on cancer therapeutics. The contract has a firm fixed price pricing type and was awarded on September 24, 2010 with a...